Opthea Limited
Opthea Limited (CKDXF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CKDXF · as of Jun 8, 2026
Key Statistics
Explore Opthea Limited Data
ckdxf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
ckdxf competitorsCKDXF
AIHLF
AMGXF
CCHWF
CLAZF
DFHLStock Performance
Full HistoryAbout Opthea Limited
Opthea Limited a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellec…
what is opthea limited · ckdxf stock overview · opthea limited company profile · who is opthea limited ceo · ckdxf OTC · opthea limited headquarters · opthea limited business segments
About Stock Overview & Key Data
Opthea Limited (CKDXF) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 25, 2011. As of the latest trading session, CKDXF stock price is $0.44, with a market capitalization of $601.9M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Opthea Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Opthea Limited reported revenue of $25384.00 and net income of -$162.8M. For detailed data — including Opthea Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Opthea Limited (CKDXF) stock price is $0.44. The stock is traded on OTC under the ticker symbol CKDXF. The 52-week range is $0.29 – $0.44.